Escitalopram Oxalate is a selective serotonin reuptake inhibitor (SSRI) indicated for major depressive disorder and generalized anxiety disorder. We supply it to US manufacturers of tablets and oral solution.
Data from PubChem (CID 146571) and FDA’s substance registry
CAS number
219861-08-2
Molecular formula
C22H23FN2O5
Molecular weight
414.4g/mol
FDA UNII
IUPAC name
(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid
InChIKey
KTGRHKOEFSJQNS-BDQAORGHSA-N
- Appearance
- Fine, white to almost white crystalline powder.
- Solubility
- Freely soluble in methanol and dimethyl sulfoxide, soluble in isotonic saline, sparingly soluble in water and ethanol, and insoluble in heptane.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
The single S-enantiomer of citalopram. The limit for the R-enantiomer is the figure to compare between sources.
On the US market
- Reference product
- LexaproNDA 021323
- Approved ANDAs
- 17 with a marketed product
- Approved forms and strengths
- Tablet 5 mg, 10 mg, 20 mg
- Oral solution 5 mg/5 mL
- Capsule 15 mg
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com
Sertraline Hydrochloride
Selective serotonin reuptake inhibitor (SSRI)
CAS 79559-97-0Duloxetine Hydrochloride
Serotonin-norepinephrine reuptake inhibitor (SNRI)
CAS 136434-34-9Bupropion Hydrochloride
Norepinephrine-dopamine reuptake inhibitor
CAS 31677-93-7Trazodone Hydrochloride
Serotonin antagonist and reuptake inhibitor
CAS 25332-39-2